Welcome: Guest | Site Use Options | Register | Login |

UbiVac LLC

UbiVac LLC

Profile last edited on: 1/14/2019
18183 SW Boones Ferry Road
Portland, OR 97224
  (503) 292-4066
Business Identifier: Immunotherapies to combat cancer.
Public Profile:
UbiVac LLC is developing a new cancer vaccine technology based on hormones and enzymes produced by tumor cells. UbiVac is a development stage biotechnology company that is focused on discovering, licensing, improving and commercializing immunotherapy products that safely generate and augment the immune response to vaccines. Preclinical studies document that UbiVac technology is significantly more effective than current gold standard vaccines at inducing tumor regression and increasing survival of tumor-bearing hosts. Based on these data a phase I clinical trial of UbiVac vaccine technology will be initiated in patients with non-small cell lung cancer (NSCLC) in the first quarter of 2008. UbiVac is also exploring the application of this approach to the development of an avain flu vaccine.

 Synopsis: Awardee Business Condition
Year Founded First SBIR Year Date of Last Award
Employee Range VC funded? IP Holdings
Revenue Range Private/Public Exchange/Symbol :

Unlock access

To unlock access to all SBIR-STTR company Profiles, a FREE site registration is required. Click here to register or login if you already have an account

Smart Office Options


Is this YOUR Company?

Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached

Do you know about this Awardees?

Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Contact information

Innovation Development Institute, LLC

   45 Beach Bluff Avenue, Suite 300
     Swampscott,  MA 01907-1542

  Tel:  (781) 595-2920